About us

ELITechGroup is a global leader in in-vitro diagnostics, serving hospitals and diagnostic laboratories in over 100 countries through a direct sales network and trusted distribution partners. The company develops, manufactures, and markets a comprehensive range of diagnostic products and solutions, including instruments, reagents, and software.

To provide tailored support to its diverse clientele, ELITechGroup is organized into three specialized business units, each focusing on specific IVD technologies and market segments: Molecular Diagnostics (MDx), Biomedical Systems (EBS), and Microbiology (EM).

At the core of ELITechGroup’s success are its unwavering commitment to customer satisfaction and a relentless drive for innovation. The company places great emphasis on delivering exceptional service and support to every customer. Innovation is not just a buzzword for ELITechGroup; it is a cornerstone of its products, reflected in its extensive intellectual property portfolio and its ability to consistently deliver cutting-edge solutions that stay ahead of technological trends. Furthermore, all products adhere to the highest global regulatory standards, ensuring safety and reliability across the board. Thanks to these advancements, ELITechGroup continues to capture an increasing share of the expanding IVD market.

With a global team of about 600 professionals, ELITechGroup is proud to be a part of Bruker Corporation.

Alongside Bruker’s other businesses in the Bruker Microbiology & Infection Diagnostics division (BMID), ELITechGroup remains deeply committed to fully meeting the evolving needs of its customers. The company continues to develop state-of-the-art technologies and innovative solutions that address the challenges faced by today’s—and tomorrow’s—laboratories.